DK1345594T3 - Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin - Google Patents

Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin

Info

Publication number
DK1345594T3
DK1345594T3 DK01989654T DK01989654T DK1345594T3 DK 1345594 T3 DK1345594 T3 DK 1345594T3 DK 01989654 T DK01989654 T DK 01989654T DK 01989654 T DK01989654 T DK 01989654T DK 1345594 T3 DK1345594 T3 DK 1345594T3
Authority
DK
Denmark
Prior art keywords
ivabradine
pharmaceutical composition
controlled release
solid pharmaceutical
thermoforming
Prior art date
Application number
DK01989654T
Other languages
English (en)
Inventor
Gilles Briault
Patrick Wuthrich
Gerald Pichon
Herve Rolland
Francois Tharrault
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1345594T3 publication Critical patent/DK1345594T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01989654T 2000-12-26 2001-12-21 Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin DK1345594T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017015A FR2818552B1 (fr) 2000-12-26 2000-12-26 Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
PCT/FR2001/004134 WO2002051387A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Publications (1)

Publication Number Publication Date
DK1345594T3 true DK1345594T3 (da) 2007-05-21

Family

ID=8858190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01989654T DK1345594T3 (da) 2000-12-26 2001-12-21 Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin

Country Status (27)

Country Link
US (1) US20040028743A1 (da)
EP (1) EP1345594B1 (da)
JP (2) JP2004518665A (da)
KR (1) KR100542472B1 (da)
CN (1) CN1203844C (da)
AT (1) ATE352290T1 (da)
AU (1) AU2002228119B2 (da)
BR (1) BR0116548A (da)
CA (1) CA2432645A1 (da)
CY (1) CY1106390T1 (da)
CZ (1) CZ304587B6 (da)
DE (1) DE60126332T2 (da)
DK (1) DK1345594T3 (da)
EA (1) EA005814B1 (da)
ES (1) ES2280420T3 (da)
FR (1) FR2818552B1 (da)
HK (1) HK1060514A1 (da)
HU (1) HU229410B1 (da)
MX (1) MXPA03005840A (da)
NO (1) NO333776B1 (da)
NZ (1) NZ526406A (da)
PL (1) PL203835B1 (da)
PT (1) PT1345594E (da)
SI (1) SI1345594T1 (da)
SK (1) SK286413B6 (da)
WO (1) WO2002051387A1 (da)
ZA (1) ZA200304441B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
FR2882553B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2010128525A2 (en) 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
PT2579860E (pt) 2010-06-14 2014-05-30 Ratiopharm Gmbh Composição farmacêutica que contém ivabradina com libertação modificada
CN101897682B (zh) * 2010-07-13 2012-02-15 石药集团欧意药业有限公司 一种伊伐布雷定或其可药用盐固体制剂及其制备方法
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
WO2015091992A1 (en) * 2013-12-20 2015-06-25 Synthon B.V. Pharmaceutical composition comprising amorphous ivabradine
EP3025705B8 (en) 2014-11-25 2018-11-28 Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi Stable ivabradine formulations
CN104398486B (zh) * 2014-12-08 2018-01-12 武汉武药科技有限公司 一种盐酸伊伐布雷定渗透泵控释片及其制备方法
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997008950A1 (en) * 1995-09-07 1997-03-13 Fuisz Technologies, Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
DE19901040A1 (de) * 1999-01-14 2000-07-20 Knoll Ag Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Also Published As

Publication number Publication date
ZA200304441B (en) 2004-06-25
MXPA03005840A (es) 2003-09-10
CZ304587B6 (cs) 2014-07-23
ES2280420T3 (es) 2007-09-16
HU229410B1 (en) 2013-12-30
HK1060514A1 (en) 2004-08-13
NO333776B1 (no) 2013-09-16
KR20030064876A (ko) 2003-08-02
EP1345594B1 (fr) 2007-01-24
NO20032737L (no) 2003-06-16
JP2004518665A (ja) 2004-06-24
HUP0302522A3 (en) 2007-09-28
EA200300667A1 (ru) 2003-12-25
PL361662A1 (en) 2004-10-04
DE60126332D1 (de) 2007-03-15
HUP0302522A2 (hu) 2003-12-29
SI1345594T1 (sl) 2007-04-30
NO20032737D0 (no) 2003-06-16
EP1345594A1 (fr) 2003-09-24
WO2002051387A8 (fr) 2004-05-13
US20040028743A1 (en) 2004-02-12
SK286413B6 (sk) 2008-09-05
CN1482901A (zh) 2004-03-17
CA2432645A1 (fr) 2002-07-04
FR2818552B1 (fr) 2003-02-07
ATE352290T1 (de) 2007-02-15
PL203835B1 (pl) 2009-11-30
CY1106390T1 (el) 2011-10-12
SK9422003A3 (en) 2003-12-02
JP2010100641A (ja) 2010-05-06
PT1345594E (pt) 2007-04-30
EA005814B1 (ru) 2005-06-30
CZ20032020A3 (cs) 2003-11-12
AU2002228119B2 (en) 2006-04-27
NZ526406A (en) 2005-08-26
CN1203844C (zh) 2005-06-01
FR2818552A1 (fr) 2002-06-28
BR0116548A (pt) 2003-12-23
DE60126332T2 (de) 2007-08-30
WO2002051387A1 (fr) 2002-07-04
KR100542472B1 (ko) 2006-01-11

Similar Documents

Publication Publication Date Title
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
DK1345594T3 (da) Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin
TW200730200A (en) Method for the preparation of a wet granulated drug product
DK1066049T3 (da) Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse
BR9916835A (pt) Composição de galantamina de liberação controlada
DK1861073T3 (da) Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed
DE50012008D1 (de) Zementzusammensetzungen, enthaltend redispergierbare Polymerisatpulver
HRP20090194T1 (en) Dry granulated composition comprising emtricitabine and tenofovir df
AU3652102A (en) Compounds and their uses
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
NO20013060D0 (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
DK1210384T3 (da) Uorganisk belægningssammensætning, en fremgangsmåde til fremstilling af denne samt anvendelse deraf
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
DK1051158T3 (da) Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering
EA200201149A1 (ru) Фармацевтические композиции и способы для предотвращения рецидива мигрени
EA200300664A1 (ru) Твердая термоформируемая фармацевтическая композиция для контролируемого высвобождения периндоприла
AR032049A1 (es) Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
BR0212254A (pt) Composição farmaceutica
PL376537A1 (pl) Kompozycje farmaceutyczne o przedłużonym, kontrolowanym uwalnianiu zawierające naładowane polimery
MXPA02012456A (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis.
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
AU2001295836A1 (en) Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
DK1144382T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 1,5-diarylpyrazoler
ECSP003358A (es) Composiciones de betahistina de liberacion controlada